Virometix appoints Dr. Pierre A. Morgon as new Chairman and Dr. Isaac Kobrinas new member of the Board of Virometix AG.
Schlieren, Switzerland (25.01.2017) – Virometix today announced the appointment of Dr. Pierre A.
Morgon, PharmD, LL.M., MBA as Chairman and Dr. Isaac Kobrin as independent member to its Board of Directors. In addition, the company announced the nomination of Emmanuel Savioz, MBA as new Chief Financial Officer. With these appointments Virometix is taking further steps to enhance professional expertise within the Board of Directors and senior management of the company. Furthermore, the Scientific Advisory Board has been strengthened with the addition of emeritus Prof. Paul-Henri Lambert, MD.